Update on the BioMarin CLN2 Clinical Trial

BioMarin announced some promising data from their CLN2 (late-infantile Batten disease) clinical trial. So far, their study is showing stabilization in the disease. To learn more about their study and the results thus far, read the article.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s